Transcatheter Valve-in-Valve Pulmonary Valve Implantation Using SAPIEN 3 for a Young-Adult Patient with Severe Heart Failure: A Case Report

Yuriko Shima, et al.

Objective: Transcatheter valve-in-valve pulmonary valve implantation (ViV-TPVI) with SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA) is effective for treating insufficient prosthetic valves in right ventricular outflow tract diseases. SAPIEN 3 is primarily used to replace failed aortic valves; therefore, there is limited published data on the outcomes of its use for ViV-TPVI. In patients with severe heart failure, every procedure can lead to collapse during TPVI. This case report aims to describe the procedural strategy, perioperative management, and short-term outcomes of ViV-TPVI with SAPIEN 3 in a patient with biventricular heart failure, where careful preparation and prerisk assessment were critical to procedural success.

Read full Article >

Failure to Recapture a Self-Expanding Evolut FX Valve Resulting in Remained in the Abdominal Aorta During a TAV-in-SAV Procedure: A Case Report

Takayuki Ogawa, et al.

Objective: The self-expanding valves used in transcatheter aortic valve implantation (TAVI) feature the ability to be recaptured before reaching the point of no recapture. We report a rare case of TAVI for surgical aortic valve dysfunction in which a self-expanding Evolut FX valve (Medtronic, Minneapolis, MN, USA) could not be recaptured and was consequently deployed in the abdominal aorta.

Read full Article >

Iatrogenic Acute Type B Aortic Dissection during Transcatheter Aortic Valve Implantation

Kayo Sugiyama, et al.

Objective: As the number of transcatheter aortic valve implantation (TAVI) procedures increases, specific complications, including aortic dissection, have been reported. Acute type B aortic dissection (ATBAD) is rare but more difficult to detect during TAVI compared to acute type A aortic dissection (ATAAD). This study presents our experience with iatrogenic ATBAD during TAVI.

Read full Article >